Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
NUPATHE (NQ: PATH)
2.790 USD  +0.010 (+0.36%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about NUPATHE
 
< Previous 1 2 3 Next >
Safeguard Scientifics to Host Investor Day on October 8, 2013
June 05, 2013
from Business Wire News Releases
NuPathe Announces Allowance of Additional U.S. Patent Application for ZECUITY
May 28, 2013
from Marketwired News Releases
NuPathe Announces First Quarter 2013 Financial Results and Operational Highlights
May 14, 2013
from Marketwired News Releases
NuPathe Announces Allowance of Additional U.S. Patent Application for NP201
May 13, 2013
from Marketwired News Releases
NuPathe to Host Conference Call to Discuss First Quarter 2013 Results on Tuesday, May 14, 2013
May 07, 2013
from Marketwired News Releases
NuPathe Announces Allowance of U.S. Patent Application for NP201
April 25, 2013
from Marketwired News Releases
Safeguard Scientifics Announces First Quarter 2013 Financial Results
April 25, 2013
from Business Wire News Releases
NuPathe Announces Fourth Quarter and Full Year 2012 Financial Results and Operational Highlights
March 26, 2013
from Marketwired News Releases
New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry's Growth in 2012
March 21, 2013
Five Star Equities Provides Stock Research on NuPathe and StemCells Read More
from Marketwired News Releases
NuPathe to Host Conference Call to Discuss Fourth Quarter and Full Year 2012 Results on Tuesday, March 26, 2013
March 19, 2013
from Marketwired News Releases
Safeguard Scientifics Announces Fourth Quarter and Full Year 2012 Financial Results
March 07, 2013
from Business Wire News Releases
FDA Approved a Total of 39 New Drugs in 2012 -- Fifteen Year High
February 07, 2013
Research Driven Investing Provides Stocks Research on Halozyme Therapeutics and NuPathe Read More
from Marketwired News Releases
NuPathe to Present at the Leerink Swann 2013 Global Healthcare Conference
February 06, 2013
from Marketwired News Releases
Wrap-Up & Commentary on Advancers: (NYSE: RAD), (NASDAQ: PATH)
January 18, 2013
from SBWire Direct - Latest Press Releases
Free Research Reports on AVEO, CLSN, PATH and VVUS Issued by the Bedford Report
January 18, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
NuPathe's Zecuity Approved by the FDA for the Acute Treatment of Migraine
January 17, 2013
First FDA-Approved Migraine Patch Read More
from Marketwired News Releases
Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012
January 07, 2013
Five Star Equities Provides Stock Research on Navidea Biopharmaceuticals and NuPathe Read More
from Marketwired News Releases
NuPathe Announces Allowance of Additional U.S. Patent Application for Zecuity
January 02, 2013
from Marketwired News Releases
Hercules Technology Growth Capital Announces Strong New Commitments in Quarter-to-Date Q4 2012 and Provides Year-to-Date 2012 Portfolio Update
December 19, 2012
from Business Wire News Releases
NuPathe Secures $8.5 Million Term Loan
November 27, 2012
from Marketwired News Releases
NuPathe Announces Third Quarter 2012 Financial Results and Operational Highlights
November 12, 2012
from Marketwired News Releases
NuPathe to Present at the 9th Annual Lazard Healthcare Conference
November 07, 2012
from Marketwired News Releases
NuPathe to Host Conference Call to Discuss Third Quarter 2012 Results on Monday, November 12, 2012
November 05, 2012
from Marketwired News Releases
Safeguard Scientifics Announces Third Quarter 2012 Financial Results
October 25, 2012
from Business Wire News Releases
NuPathe Announces Closing of $28 Million Private Placement and Changes to Its Board of Directors
October 23, 2012
from Marketwired News Releases
NuPathe Granted Financial Viability Exception by NASDAQ
October 12, 2012
from Marketwired News Releases
NuPathe to Present at the Safeguard Scientifics Investor Day 2012
October 08, 2012
from Marketwired News Releases
Safeguard Scientifics Announces Webcast for Investor Day 2012
October 08, 2012
from Business Wire News Releases
NuPathe Announces $28 Million Private Placement
September 25, 2012
from Marketwired News Releases
Safeguard Scientifics Announces Investor Day 2012 Agenda
September 20, 2012
from Business Wire News Releases
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here